Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial
Aung Naing, Deborah J. Wong, Jeffrey R. Infante, W. Michael Korn, Raid Aljumaily, Kyriakos P. Papadopoulos, Karen A. Autio, Shubham Pant, Todd M. Bauer, Alexandra Drakaki, Naval G. Daver, Annie Hung, Navneet Ratti, Scott McCauley, Peter Van Vlasselaer, Rakesh Verma, David Ferry, Martin Oft, Adi Diab, Edward B. GaronNizar M. Tannir
Dive into the research topics of 'Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial'. Together they form a unique fingerprint.